— Products launched under the kathy ireland® Health & Wellness, Chef Andre Carthen and I’M1 Brands
— CBD products address a market estimated to be worth $2.1 billion by 2020 (Hemp Business Journal/forbes.com)
— Products are CBD pain-relieving cream, CBD oral spray, & CBD edibles
— Products will be available in early Summer 2018 at in-store and online retailers nationwide
LOS ANGELES–(BUSINESS WIRE)–Level Brands Inc. (NYSE American: LEVB), an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses, and Vancouver-based Isodiol International Inc. (CSE: ISOL, OTCQB: ISOLF), a global bioactive phytoceutical innovator, specializing in the development of pharmaceutical and wellness products, announced today the launch of their newest jointly developed cannabidiol (CBD) products. The products are CBD pain-relieving cream, marketed under LEVB subsidiary Ireland Men One (I’M1); CBD oral sprays marketed under BeTrū | kathy ireland® Health & Wellness; and CBD edibles, marketed under Chef Andre Carthen Edibles. The new products will be available in early Summer 2018 at in-store and online retailers nationwide. According to The Hemp Business Journal (as reported by forbes.com), the CBD market will grow to $2.1 billion by 2020.
In January 2018, Level Brands and Isodiol signed a license agreement, to work together to develop consumer products for kathy ireland® Health & Wellness, a licensor to Level Brands; products under the Chef Andre Carthen and Nicholas Walker brands, also licensors to Level Brands; as well as products for Level Brands subsidiary I’M1, the company’s lifestyle brand for millennial men. The license agreement is valued at $32 million.
“Our collaboration with Level Brands is taking a big step forward today,” said Marcos Agramont, CEO of Isodiol. “When we established this partnership, we envisioned bringing a variety of consistent, highly bioactive CBD products to the market and today is just the early stages of this process. Through Kathy’s large network and consumer base, not only are we able to target a variety of new mainstream channels, but we are also able to further achieve our goal of helping people around the globe understand how CBD is beneficial for the human body.”
“When we announced the extension of our license agreement with Isodiol this past January, we said that our vision is that Isodiol will become the leading CBD company in the world,” says Kathy Ireland, Level Brands’ Chairman Emeritus and Chief Brand Strategist. “The products we’re launching, take us in that direction in a powerful way. We continue to believe, based on our exhaustive research and decades of brand building, that the CBD industry will see enormous growth over the next decade on a global scale. Hemp has many natural and important uses that are beneficial in countless ways. It is important for people to remember that hemp, without THC, is similar to a grape without fermentation. It has no undesired psychological side effects. The Level Brands and Isodiol collaboration is bringing, and will continue to bring to market, the best quality hemp-derived CBD products, without any psychotropic elements.”
Martin Sumichrast, Chairman and CEO of Level Brands, said, “Level Brands and Isodiol have embarked on a decade-long partnership which has the potential to not only sell a significant amount of consumer-branded products worldwide but also bring to market new, innovative means that I believe will provide consumers the best benefits of CBD. The products we’re launching represent the cutting edge of innovation and a new way of thinking about CBD.”
“CBD is here, it’s happening, and it’s only going to be bigger,” said Tommy Meharey, Marine, millennial father, lifestyle leader, and the youngest board member of kathy ireland® Worldwide – who co-founded I’M1 with Kathy Ireland. “Steadily, minds are changing as people are becoming more educated and informed about what CBD is and how it is different than THC-based products. CBD is an amazing compound and I’m overjoyed that we are part of this great and fast-growing movement.”
“We’re thrilled at the debut of CBD edibles,” said celebrity Chef Andre Carthen, also known as the Fit Chef. Chef Andre has contributed to a New York Times #1 best seller and has appeared on numerous network television shows, and national magazines and newspapers. “In CBD edibles, the CBD is released slowly as the food is digested, and therefore they provide those taking them with longer lasting relief.”
Stephen Roseberry and Jon Carrasco serve as President & CMO, and Global Creative Director, respectively, for kathy ireland® Worldwide and all of its Level Brands licensing entities, including I’M1,
kathy ireland® Health & Wellness, and EE1, the brand management subsidiary, co-founded by Nic Mendoza. All CBD products are THC-free and non-psychoactive while focusing on the natural, positive effects CBD has on our bodies. All products use hemp-derived, 99%+ pure, bioactive, and pharmaceutical-grade CBD. The products promote a holistic and natural lifestyle and are made in the USA.
About Level Brands Inc. (www.LevelBrands.com)
Level Brands creates bold, unconventional, and socially responsible branding for leading businesses. Level Brands specializes in corporate brand management and consumer products marketing art, beauty, fashion, health and wellness, and entertainment. Licensed brand marketing is at the core of the Level Brands businesses, among which are Ireland Men One or I’M1, for millennial men and the women who love them; Encore Endeavor One or EE1, corporate brand management and producer of experiential entertainment events and products across multiple platforms; kathy ireland® Health & Wellness; and Beauty & Pin-Ups, Level Brands’ hair-care and disruptive women’s-products brand.
About Isodiol International Inc. (www.Isodiol.com)
Isodiol International, Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products. Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products. Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio, and aggressively continuing its international expansion into Latin America, Asia, and Europe.
This press release contains certain forward-looking statements that are based on current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as “should,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” and “proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in Level Brands Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2017 as filed with the Securities and Exchange Commission (the “SEC”) on December 26, 2017 and our other filings with the SEC. Level Brands Inc. does not undertake any duty to update any forward-looking statements except as may be required by law.